Global Health · NSE: MEDANTA · BSE: 543654
Q2 FY26 results · Jul–Sep 2025
Global Health reported revenue from operations of ₹1,099.22 crore (up 14.9% from Q2 FY25) and net profit of ₹158.40 crore (up 21.1% from Q2 FY25) for Q2 FY26 (Jul–Sep 2025), on a consolidated basis.
| Item | Q2 FY26 | Q2 FY25 | YoY | Q1 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,099.22 | 956.55 | +14.9% | 1,030.84 | +6.6% |
| Other income | 19.73 | 18.22 | +8.3% | 20.46 | −3.6% |
| Total income | 1,118.95 | 974.77 | +14.8% | 1,051.29 | +6.4% |
| Profit before tax | 199.81 | 181.10 | +10.3% | 208.14 | −4.0% |
| Net profit for the period | 158.40 | 130.82 | +21.1% | 158.98 | −0.4% |
| Attributable to shareholders of the company | 158.44 | — | — | 159.01 | −0.4% |
| EPS, basic (₹) | 5.89 | 4.87 | +20.9% | 5.92 | −0.5% |
| Net margin (%) | 14.4 | 13.7 | 15.4 |
| Item | Q2 FY26 | Q2 FY25 | YoY | Q1 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 926.43 | 664.61 | +39.4% | 882.16 | +5.0% |
| Other income | 22.80 | 23.58 | −3.3% | 23.14 | −1.5% |
| Total income | 949.23 | 688.18 | +37.9% | 905.29 | +4.9% |
| Profit before tax | 185.05 | 143.61 | +28.9% | 198.25 | −6.7% |
| Net profit for the period | 140.20 | 104.47 | +34.2% | 151.96 | −7.7% |
| EPS, basic (₹) | 5.22 | 3.89 | +34.2% | 5.66 | −7.8% |
| Net margin (%) | 15.1 | 15.7 | 17.2 |
Consolidated
- Filed with BSE
- 07 Nov 2025, 19:23 IST
- Board meeting
- 07 Nov 2025
- Period
- 01 Jul 2025 to 30 Sep 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 07 Nov 2025, 19:23 IST
- Board meeting
- 07 Nov 2025
- Period
- 01 Jul 2025 to 30 Sep 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE